0
Facebook Twitter Pinterst Linkedin Blog Online Continuing Education for Healthcare Professionals
 

SALE

$20

REG. $40

Treating ADHD and Comorbid Disorders: Psychosocial and Psychopharmacological Interventions

Steven R. Pliszka, MD

CE Credit: 6 Hours

Target Audience: Psychology CE | Counseling CE | Social Work CE | Occupational Therapy CEUs | Marriage & Family Therapy CE | School Psychology CE

Learning Level: Intermediate

Course Type: Test Only

Course Abstract

This is a test only course (book not included). The book can be purchased from Amazon or some other source.

This CE test is based on the book "Treating ADHD and Comorbid Disorders: Psychosocial and Psychopharmacological Interventions" (2009, 244 pages). Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) frequently experience co-occurring problems with aggression, mood swings, tics, anxiety, or depression. Organized around detailed case presentations, this highly informative book helps the clinician make sound decisions when assessing and treating the full range of ADHD comorbidities. Experienced child psychiatrist Steven Pliszka offers straightforward guidance on how to navigate diagnostic challenges, develop an individualized medication regimen, minimize health risks and side effects, collaborate successfully with parents, and tailor psychosocial treatments to each family's needs. A reproducible structured interview facilitates sorting out symptoms and distinguishing between different comorbid disorders. 

Course #60-85 | 25 posttest questions

Spring Cleaning Sale Ends 6/30/2013

Learning Objectives

1.Define and discuss the issues of comorbidity in clinical practice
2.Explore the impact a comorbid diagnosis of ODD and CD with ADHD has on therapeutic determinations
3.Analyze the studies of Wozniak and CMAP to identify appropriate treatment algorithms for children with ADHD and aggression
4.Understand differentiation in treatment modalities for children and teens with a diagnosis of ADHD and BP
5.Recognize the implications of comorbid diagnoses of ADHD and MDD on treatment decisions
6.Describe how the presence of anxiety affects the treatment of children diagnosed with ADHD
7.Describe the importance of the relationship between ID, ASD and ADHD in making medication decisions
CE INFORMATION
Professional Development Resources is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Professional Development Resources maintains responsibility for all programs and content. Professional Development Resources is also approved by the Florida Board of Psychology and the Office of School Psychology and is CE Broker compliant (#50-1635).
COURSE DIRECTIONS

This is a test only course (book not included). The book (or e-book) can be purchased from Amazon.

Disclosure: No commercial support was received for this CE activity.

 

About the Author(s)

Steven R. Pliszka, MD, is Professor of Psychiatry at the University of Texas Health Science Center at San Antonio, where he serves as Vice Chair of the Department of Psychiatry and Chief of the Division of Child and Adolescent Psychiatry. Dr. Pliszka has been involved in numerous clinical trials of psychopharmacological agents in the treatment of ADHD, as well as bipolar disorder of childhood. Recent research activities include the neuroimaging of stimulant response in patients with ADHD and the study of mood-stabilizing medication in the treatment of aggression. Dr. Pliszka personally cares for over 500 children with ADHD, developmental disabilities, and other psychiatric disorders; he also teaches psychopharmacology and neurobiology to medical students and psychiatry residents. He was the principal author of the Practice Parameters of the American Academy of Child and Adolescent Psychiatry for the diagnosis and treatment of ADHD. He is currently the principal investigator for Services Uniting Pediatrics and Psychiatry Outreaching to Texas (SUPPORT), a state-funded initiative to increase the availability of mental health services to children in the Medicaid program by placing mental health professionals in pediatric primary care offices.


Customer Reviews